FTSE All-Share
4.991,61
PKT
+5,27
PKT
+0,11
%
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 15.11.18 | BP kaufen | RBC Capital Markets | |
| 15.11.18 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 14.11.18 | Vodafone Group buy | Deutsche Bank AG | |
| 13.11.18 | National Grid Neutral | Credit Suisse Group | |
| 13.11.18 | Vodafone Group Outperform | Credit Suisse Group | |
| 13.11.18 | Diageo Hold | Deutsche Bank AG | |
| 13.11.18 | Vodafone Group Sell | Société Générale Group S.A. (SG) | |
| 13.11.18 | BAT buy | UBS AG | |
| 13.11.18 | Vodafone Group Hold | Jefferies & Company Inc. | |
| 13.11.18 | Diageo buy | UBS AG | |
| 13.11.18 | Vodafone Group buy | UBS AG | |
| 13.11.18 | Vodafone Group overweight | Barclays Capital | |
| 13.11.18 | Vodafone Group Strong Buy | CFRA | |
| 13.11.18 | Vodafone Group Outperform | RBC Capital Markets | |
| 13.11.18 | Vodafone Group Outperform | Bernstein Research | |
| 13.11.18 | BAT buy | CFRA | |
| 13.11.18 | AstraZeneca buy | Deutsche Bank AG | |
| 13.11.18 | Vodafone Group overweight | JP Morgan Chase & Co. | |
| 12.11.18 | BAT buy | Goldman Sachs Group Inc. | |
| 12.11.18 | Diageo buy | Goldman Sachs Group Inc. | |
| 12.11.18 | Diageo Outperform | Credit Suisse Group | |
| 12.11.18 | Glencore buy | Goldman Sachs Group Inc. | |
| 12.11.18 | Rio Tinto Neutral | Goldman Sachs Group Inc. | |
| 12.11.18 | AstraZeneca Reduce | HSBC | |
| 12.11.18 | AstraZeneca buy | Deutsche Bank AG | |
| 12.11.18 | BAT overweight | Barclays Capital | |
| 09.11.18 | AstraZeneca Outperform | Credit Suisse Group | |
| 09.11.18 | National Grid buy | Société Générale Group S.A. (SG) | |
| 09.11.18 | Lloyds Banking Group Outperform | Credit Suisse Group | |
| 09.11.18 | Shell (ex Royal Dutch Shell) overweight | JP Morgan Chase & Co. | |
| 09.11.18 | Shell (ex Royal Dutch Shell) overweight | JP Morgan Chase & Co. | |
| 09.11.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 09.11.18 | HSBC Underperform | RBC Capital Markets | |
| 09.11.18 | National Grid Neutral | Goldman Sachs Group Inc. | |
| 09.11.18 | AstraZeneca Hold | CFRA | |
| 09.11.18 | AstraZeneca overweight | Barclays Capital | |
| 09.11.18 | Barclays kaufen | Credit Suisse Group | |
| 08.11.18 | AstraZeneca Neutral | UBS AG | |
| 08.11.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 08.11.18 | National Grid overweight | JP Morgan Chase & Co. |